PPARA and fatty liver disease: Activated the PPARα signaling by inhibiting ACOX1, which then promoted mitochondrial fatty acid β-oxidation by upregulating CPT1A, therefore inhibiting hepatocyte lipid accumulation and relieving hepatic steatosis